Zelluna ASA (OSL:ZLNA)
Norway · Delayed Price · Currency is NOK 13.80
-0.10 (-0.71%)
At close: Aug 1, 2025
Zelluna ASA Company Description
Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway.
Zelluna ASA
| Country | Norway |
| Founded | 2016 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 22 |
| CEO | Namir Hassan |
Contact Details
Address: Ullernchausséen 64 Oslo, 0379 Norway | |
| Phone | 47 22 84 00 80 |
| Website | zelluna.com |
Stock Details
| Ticker Symbol | ZLNA |
| Exchange | Oslo Børs |
| Fiscal Year | January - December |
| Reporting Currency | NOK |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Namir Hassan | Chief Executive Officer |
| Hans Eid | Chief Financial Officer |
| Anders Holm | Chief Operating Officer |